Adagrasib/Panitumumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of adagrasib and panitumumab that may be used in the treatment of KRAS G12C mutation-positive colorectal cancer, appendiceal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Adagrasib-Panitumumab - Adagrasib/Panitumumab - Krazati/Vectibix Regimen - Panitumumab-Adagrasib - Panitumumab/Adagrasib